IC
LENZ

IEQ Capital’s LENZ Therapeutics LENZ Stock Holding History

IEQ Capital’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169K Buy
29,692
+10,885
+58% +$87.7K ﹤0.01% 1867
2026
Q1 		$172K Buy
+18,807
New +$264K ﹤0.01% 1730

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

IEQ Capital's LENZ Position: Q2 2026 in Review

IEQ Capital increased its LENZ Therapeutics (LENZ) stake by 58% in Q2 2026, buying an estimated $87.7K and bringing the position to 29,692 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #1867.

IEQ Capital first reported a position in LENZ in Q1 2026 and has held it in 2 quarters since. The position peaked at $172K in Q1 2026. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • IEQ Capital held 29,692 shares of LENZ Therapeutics worth $169K as of Q2 2026.
  • IEQ Capital bought 10,885 LENZ Therapeutics shares in Q2 2026, an estimated $87.7K.
  • LENZ Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1867 holding.
  • IEQ Capital first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • IEQ Capital's LENZ Therapeutics position peaked at $172K in Q1 2026.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.